Bouhlal Hicham, Chomont Nicolas, Réquena Mary, Nasreddine Nadine, Saidi Héla, Legoff Jérôme, Kazatchkine Michel D, Bélec Laurent, Hocini Hakim
Université René Descartes Paris V and Institut National de la Santé et de la Recherche Médicale, Unité 743, Institut des Cordeliers, Paris, France.
J Immunol. 2007 Jan 15;178(2):1086-95. doi: 10.4049/jimmunol.178.2.1086.
In the present study, we demonstrated that opsonization of primary HIV-1 with human complement enhances infection of immature monocyte-derived dendritic cells (iDC) and transmission in trans of HIV to autologous CD4(+) T lymphocytes. Infection of iDC by opsonized primary R5- and X4-tropic HIV was increased 3- to 5-fold as compared with infection by the corresponding unopsonized HIV. Enhancement of infection was dependent on CR3 as demonstrated by inhibition induced by blocking Abs. The interaction of HIV with CCR5 and CXCR4 on iDC was affected by opsonization. Indeed, stromal-derived factor-1 was more efficient in inhibiting infection of iDC with opsonized R5-tropic HIV-1(BaL) (45%) than with heat-inactivated complement opsonized virus and similarly RANTES inhibited more efficiently infection of iDC with opsonized X4-tropic HIV-1(NDK) (42%) than with heat-inactivated complement opsonized virus. We also showed that attachment of complement-opsonized virus to DC-specific ICAM-grabbing nonintegrin (DC-SIGN) molecule on iDC and HeLa DC-SIGN(+) CR3(-) cells was 46% and 50% higher compared with heat-inactivated complement opsonized virus, respectively. Hence, Abs to DC-SIGN suppressed up to 80% and 60% the binding of opsonized virus to HeLa cells and iDC, respectively. Furthermore, Abs to DC-SIGN inhibited up to 70% of the infection of iDC and up to 65% of infection in trans of autologous lymphocytes with opsonized virus. These results further demonstrated the role of DC-SIGN in complement opsonized virus uptake and infection. Thus, the virus uses complement to its advantage to facilitate early steps leading to infection following mucosal transmission of HIV.
在本研究中,我们证明,用人补体调理原发性HIV-1可增强未成熟单核细胞衍生树突状细胞(iDC)的感染以及HIV向自体CD4(+) T淋巴细胞的反式传递。与相应的未调理HIV感染相比,调理过的原发性R5和X4嗜性HIV对iDC的感染增加了3至5倍。如阻断抗体诱导的抑制作用所示,感染增强依赖于CR3。HIV与iDC上CCR5和CXCR4的相互作用受调理作用影响。实际上,基质衍生因子-1抑制调理过的R5嗜性HIV-1(BaL)感染iDC(45%)比抑制热灭活补体调理的病毒更有效,同样,RANTES抑制调理过的X4嗜性HIV-1(NDK)感染iDC(42%)比抑制热灭活补体调理的病毒更有效。我们还表明,与热灭活补体调理的病毒相比,补体调理的病毒分别与iDC和HeLa DC-SIGN(+) CR3(-)细胞上的DC特异性ICAM结合非整合素(DC-SIGN)分子的附着率分别高46%和50%。因此,抗DC-SIGN抗体分别抑制调理过的病毒与HeLa细胞和iDC结合达80%和60%。此外,抗DC-SIGN抗体分别抑制高达70%的iDC感染和高达65%的调理过的病毒对自体淋巴细胞的反式感染。这些结果进一步证明了DC-SIGN在补体调理的病毒摄取和感染中的作用。因此,病毒利用补体的优势来促进HIV黏膜传播后导致感染的早期步骤。